Literature DB >> 11994463

IL-1 regulates cytoskeletal organization in osteoclasts via TNF receptor-associated factor 6/c-Src complex.

Ichiro Nakamura1, Yuho Kadono, Hiroshi Takayanagi, Eijiro Jimi, Tsuyoshi Miyazaki, Hiromi Oda, Kozo Nakamura, Sakae Tanaka, Gideon A Rodan, Le T Duong.   

Abstract

Targeted disruption of either c-Src or TNFR-associated factor 6 (TRAF6) in mice causes osteoclast dysfunction and an osteopetrotic phenotype, suggesting that both molecules play important roles in osteoclastic bone resorption. We previously demonstrated that IL-1 induces actin ring formation and osteoclast activation. In this study, we examined the relationship between IL-1/TRAF6-dependent and c-Src-mediated pathways in the activation of osteoclast-like cells (prefusion cells (pOCs); multinucleated cells) formed in the murine coculture system. In normal pOCs, IL-1 induces actin ring formation and tyrosine phosphorylation of p130(Cas), a known substrate of c-Src. However, in Src-deficient pOCs, p130(Cas) was not tyrosine phosphorylated following IL-1 treatment. In normal pOCs treated with IL-1, anti-TRAF6 Abs coprecipitate p130(Cas), protein tyrosine kinase 2, and c-Src. In Src-deficient pOCs, this molecular complex was not detected, suggesting that c-Src is required for formation of the TRAF6, p130(Cas), and protein tyrosine kinase 2 complex. Moreover, an immunocytochemical analysis revealed that in osteoclast-like multinucleated cells, IL-1 induced redistribution of TRAF6 to actin ring structures formed at the cell periphery, where TRAF6 also colocalized with c-Src. Taken together, these data suggest that IL-1 signals feed into the tyrosine kinase pathways through a TRAF6-Src molecular complex, which regulates the cytoskeletal reorganization essential for osteoclast activation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11994463     DOI: 10.4049/jimmunol.168.10.5103

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  22 in total

1.  Alpha-lipoic acid suppresses the development of collagen-induced arthritis and protects against bone destruction in mice.

Authors:  Eun Young Lee; Chang-Keun Lee; Ki-Up Lee; Joong Yeol Park; Kyung-Ja Cho; You Sook Cho; Hee Ran Lee; Se Hwan Moon; Hee-Bom Moon; Bin Yoo
Journal:  Rheumatol Int       Date:  2006-08-31       Impact factor: 2.631

Review 2.  Involvement of alpha(v)beta3 integrins in osteoclast function.

Authors:  Ichiro Nakamura; Le T Duong; Sevgi B Rodan; Gideon A Rodan
Journal:  J Bone Miner Metab       Date:  2007-10-25       Impact factor: 2.626

3.  A novel osteoclast precursor cell line, 4B12, recapitulates the features of primary osteoclast differentiation and function: enhanced transfection efficiency before and after differentiation.

Authors:  Shigeru Amano; Keisuke Sekine; Lynda F Bonewald; Yoshihiro Ohmori
Journal:  J Cell Physiol       Date:  2009-10       Impact factor: 6.384

4.  Inhibition of the classical NF-kappaB pathway prevents osteoclast bone-resorbing activity.

Authors:  Niroshani S Soysa; Neil Alles; Hitoyata Shimokawa; Eijiro Jimi; Kazuhiro Aoki; Keiichi Ohya
Journal:  J Bone Miner Metab       Date:  2009-01-27       Impact factor: 2.626

Review 5.  The diverse functions of Src family kinases in macrophages.

Authors:  Clare L Abram; Clifford A Lowell
Journal:  Front Biosci       Date:  2008-05-01

6.  Glucocorticoids suppress bone formation via the osteoclast.

Authors:  Hyun-Ju Kim; Haibo Zhao; Hideki Kitaura; Sandip Bhattacharyya; Judson A Brewer; Louis J Muglia; F Patrick Ross; Steven L Teitelbaum
Journal:  J Clin Invest       Date:  2006-07-27       Impact factor: 14.808

7.  TRAF6 protein couples Toll-like receptor 4 signaling to Src family kinase activation and opening of paracellular pathway in human lung microvascular endothelia.

Authors:  Anguo Liu; Ping Gong; Sang W Hyun; Kent Z Q Wang; Elizabeth A Cates; Darren Perkins; Douglas D Bannerman; Adam C Puché; Vladimir Y Toshchakov; Shengyun Fang; Philip E Auron; Stefanie N Vogel; Simeon E Goldblum
Journal:  J Biol Chem       Date:  2012-03-23       Impact factor: 5.157

8.  Bone is not essential for osteoclast activation.

Authors:  Karen Fuller; Jade L Ross; Kinga A Szewczyk; Raymond Moss; Tim J Chambers
Journal:  PLoS One       Date:  2010-09-17       Impact factor: 3.240

Review 9.  CAS proteins in normal and pathological cell growth control.

Authors:  Nadezhda Tikhmyanova; Joy L Little; Erica A Golemis
Journal:  Cell Mol Life Sci       Date:  2009-11-25       Impact factor: 9.261

10.  Ubiquitin-editing enzyme A20 promotes tolerance to lipopolysaccharide in enterocytes.

Authors:  Jin Wang; Yannan Ouyang; Yigit Guner; Henri R Ford; Anatoly V Grishin
Journal:  J Immunol       Date:  2009-07-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.